These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 31505389)

  • 1. Generation of an induced pluripotent stem cell line (SDQLCHi008-A) from a patient with ASD and DD carrying an 830 kb de novo deletion at chr7q11.22 including the exon 1 of AUTS2 gene.
    Yang X; Zhou T; Zhang H; Li Y; Dong R; Liu N; Pan G; Liu Y; Gai Z
    Stem Cell Res; 2019 Oct; 40():101557. PubMed ID: 31505389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De novo exon 1 deletion of AUTS2 gene in a patient with autism spectrum disorder and developmental delay: a case report and a brief literature review.
    Liu Y; Zhao D; Dong R; Yang X; Zhang Y; Tammimies K; Uddin M; Scherer SW; Gai Z
    Am J Med Genet A; 2015 Jun; 167(6):1381-5. PubMed ID: 25851617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of human induced pluripotent stem cell line (SDQLCHi060-A) from a patient with AUTS2 syndrome carrying a heterozygous mutation in AUTS2 gene.
    Gao C; Liu Y; Liu N; Li Z; Yang X; Yang Y; Xi Y; Tian J; Gai Z
    Stem Cell Res; 2023 Dec; 73():103242. PubMed ID: 37948839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germ cell mosaicism for AUTS2 exon 6 deletion.
    Gieldon L; Jauch A; Obeid K; Kaufmann L; Hinderhofer K; Haug U; Moog U
    Am J Med Genet A; 2021 Apr; 185(4):1261-1265. PubMed ID: 33577136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of iPSC line (GIBHi001-A) from a patient with autism spectrum disorder.
    Li S; Zhao H; Huang R; He L; Tian C; Huang H; Han X; Tang F; Lin Z; Deng S; Zhou J; Li Z
    Stem Cell Res; 2019 Oct; 40():101571. PubMed ID: 31520889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of an induced pluripotent stem cell (iPSC) line from a 9-year old male with autism spectrum disorder (ASD).
    Varga E; Nemes C; Bock I; Táncos Z; Berzsenyi S; Lévay G; Román V; Kobolák J; Dinnyés A
    Stem Cell Res; 2017 May; 21():19-22. PubMed ID: 28677532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An induced pluripotent stem cells line (SDQLCHi014-A) derived from urine cells of a patient with ASD and hyperactivity carrying a 303 kb de novo deletion at chr3p26.1 implicating GRM7 gene.
    Yang X; Liu Y; Zhou T; Zhang H; Dong R; Li Y; Liu N; Liu Y; Gai Z
    Stem Cell Res; 2019 Dec; 41():101635. PubMed ID: 31707215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De novo single exon deletion of AUTS2 in a patient with speech and language disorder: a review of disrupted AUTS2 and further evidence for its role in neurodevelopmental disorders.
    Amarillo IE; Li WL; Li X; Vilain E; Kantarci S
    Am J Med Genet A; 2014 Apr; 164A(4):958-65. PubMed ID: 24459036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation and characterization of PBMCs-derived human induced pluripotent stem cell (iPSC) line SDQLCHi051-A from an autism spectrum disorder patient with compound CHD8 gene mutations.
    Fan Y; Li Y; Yang X; Zhang H; Wang B; Guan J; Gao J; Ma X; Liu Y
    Stem Cell Res; 2023 Jun; 69():103114. PubMed ID: 37229974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel 14q11.2 microduplication including the CHD8 and SUPT16H genes associated with developmental delay.
    Smyk M; Poluha A; Jaszczuk I; Bartnik M; Bernaciak J; Nowakowska B
    Am J Med Genet A; 2016 May; 170A(5):1325-9. PubMed ID: 26834018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of an induced pluripotent stem cell line from a patient with autism spectrum disorder and SCN2A haploinsufficiency.
    Sampaio GLA; Martins GLS; Paredes BD; Nonaka CKV; da Silva KN; Rossi EA; Dos Santos RR; Soares MBP; Souza BSF
    Stem Cell Res; 2019 Aug; 39():101488. PubMed ID: 31272037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of a human induced pluripotent stem cell line (SJTUXHi002-A) from an individual with autism spectrum disorder carrying a heterozygous mutation in GRIA2.
    Ji Y; Lv H; Chen Z; Yu J; Fang S; Li F
    Stem Cell Res; 2022 Apr; 60():102676. PubMed ID: 35134694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole Exome Sequencing Reveals a Novel
    Palumbo P; Di Muro E; Accadia M; Benvenuto M; Di Giacomo MC; Castellana S; Mazza T; Castori M; Palumbo O; Carella M
    Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33562463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CHD8 intragenic deletion associated with autism spectrum disorder.
    Stolerman ES; Smith B; Chaubey A; Jones JR
    Eur J Med Genet; 2016 Apr; 59(4):189-94. PubMed ID: 26921529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of a Duchenne muscular dystrophy patient-derived induced pluripotent stem cell line carrying a deletion of exons 51-53 of the dystrophin gene (CCMi003-A).
    Rovina D; Castiglioni E; Farini A; Bellichi M; Gervasini C; Paganini S; Di Segni M; Santoro R; Torrente Y; Pompilio G; Gowran A
    Stem Cell Res; 2019 Oct; 40():101544. PubMed ID: 31465894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attention Deficit Hyperactivity and Autism Spectrum Disorders as the Core Symptoms of AUTS2 Syndrome: Description of Five New Patients and Update of the Frequency of Manifestations and Genotype-Phenotype Correlation.
    Sanchez-Jimeno C; Blanco-Kelly F; López-Grondona F; Losada-Del Pozo R; Moreno B; Rodrigo-Moreno M; Martinez-Cayuelas E; Riveiro-Alvarez R; Fenollar-Cortés M; Ayuso C; Rodríguez de Alba M; Lorda-Sanchez I; Almoguera B
    Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of EHMT1 mutant induced pluripotent stem cell (iPSC) line from a 11-year-old Kleefstra syndrome (KS) patient with autism and normal intellectual performance.
    Varga E; Nemes C; Táncos Z; Bock I; Berzsenyi S; Lévay G; Román V; Kobolák J; Dinnyés A
    Stem Cell Res; 2016 Nov; 17(3):531-533. PubMed ID: 27789404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of an induced pluripotent stem cell line (XHCSUi001-A) from urine cells of a patient with spinocerebellar ataxia type 3.
    He L; Ye W; Chen Z; Wang C; Zhao H; Li S; Peng L; Han X; Zhou T; Li Z; Tang B; Jiang H
    Stem Cell Res; 2019 Oct; 40():101555. PubMed ID: 31491691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of two induced pluripotent stem cell lines from patients with unbalanced translocation (3;22).
    Ma Y; Zhang H; Yang X; Li Y; Guan J; Zhang K; Huang Y; Pan G; Gai Z; Liu Y
    Stem Cell Res; 2019 Oct; 40():101545. PubMed ID: 31472451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation and characterization of an induced pluripotent stem cell (iPSC) line SDQLCHi063-A from peripheral blood mononuclear cells of a patient with Maturity-onset diabetes of the young type 2 carrying GCK exon 1 deletion.
    Gao M; Li X; Lv Y; Yang X; Liu Y; Gai Z
    Stem Cell Res; 2024 Jun; 77():103389. PubMed ID: 38507882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.